ISCA MEDICAL PRACTICE — All Prescriptions & Medications — Page 11
Practice Code: L83099 | EXETER, EX1 2DW
Showing results 501-538 of 538
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 12 | 240 | £60 | -18.4% ▼ | |
| 12 | 300 | £563 | +205.1% ▲ | |
| 12 | 90 | £137 | -27.3% ▼ | |
| 12 | 360 | £1.3K | +1.9% vs avg | |
| Nizatidine | 11 | 360 | £824 | -68.0% ▼ |
| Acrivastine | 11 | 616 | £181 | -10.7% ▼ |
| Levomepromazine maleate | 11 | 266 | £245 | +19.8% ▲ |
| Lisdexamfetamine dimesylate | 11 | 308 | £641 | -90.8% ▼ |
| Rasagiline mesilate | 11 | 308 | £220 | -70.4% ▼ |
| Bupropion hydrochloride | 11 | 330 | £219 | +1.8% vs avg |
| Pivmecillinam hydrochloride | 11 | 1,200 | £617 | -79.1% ▼ |
| Medroxyprogesterone acetate | 11 | 332 | £78 | -71.3% ▼ |
| Exemestane | 11 | 330 | £63 | -66.1% ▼ |
| Powder thickener - starch based (0913161) | 11 | 14.8K | £395 | -23.4% ▼ |
| Atropine sulfate | 11 | 440 | £358 | -13.7% ▼ |
| 11 | 251 | £105 | -40.0% ▼ | |
| 11 | 166 | £631 | -60.5% ▼ | |
| 11 | 190 | £437 | -56.7% ▼ | |
| 11 | 190 | £128 | -74.5% ▼ | |
| 11 | 96 | £510 | +62.1% ▲ | |
| 11 | 660 | £137 | -62.6% ▼ | |
| 11 | 330 | £142 | -37.0% ▼ | |
| Sodium picosulfate | 10 | 2,000 | £170 | -72.4% ▼ |
| Naloxegol | 10 | 300 | £525 | -27.5% ▼ |
| Omega-3-acid ethyl esters | 10 | 1,008 | £487 | -52.7% ▼ |
| Glycopyrronium bromide | 10 | 300 | £261 | -73.2% ▼ |
| Biphasic insulin aspart | 10 | 200 | £1.2K | -90.2% ▼ |
| Glimepiride | 10 | 300 | £8 | -89.2% ▼ |
| Metformin hydrochloride/sitagliptin | 10 | 560 | £98 | -73.3% ▼ |
| Duloxetine hydrochloride | 10 | 280 | £63 | -80.5% ▼ |
| Powder 6.7 kcal/g energy and protein fortifier (0913141) | 10 | 280 | £242 | +27.3% ▲ |
| Betamethasone esters | 10 | 780 | £80 | -83.4% ▼ |
| Erythromycin | 10 | 390 | £152 | -26.4% ▼ |
| Diclofenac sodium | 10 | 800 | £582 | -58.3% ▼ |
| 10 | 95 | £759 | -29.0% ▼ | |
| 10 | 680 | £359 | -48.3% ▼ | |
| 10 | 1,630 | £81 | -90.2% ▼ | |
| 10 | 220 | £1.2K | -19.9% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.